TRANSCENTA HOLDING - A global Fully Integrated Biotherapeutics Company

Transcenta, biologics, antibody

TRANSCENTA HOLDING - A global Fully Integrated Biotherapeutics Company

contact
Scientific Publications

Shanghai’s STAR rises as a destination for biotech IPOs

16 Nov, 2019

An analysis of recent and expected IPOs of Chinese biotechs suggests Shanghai’s STAR market could quickly catch up to, or even surpass, HKEX in the number of biotechs completing IPOs on the exchange...


VIEW FULL ARTICLE→

0 个附件